Chronic Lung Disease of Prematurity Terminated Phase 2 Trials for 1-Palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)) (DB11331)

Also known as: BPD - Bronchopulmonary Dysplasia / Bronchopulmonary Dysplasia (BPD) / Broncho Pulmonary Dysplasia / Bronchopulmonary Dysplasia / Other chronic respiratory diseases originating in the perinatal period / Bronchopulmonary dysplasia of newborn (disorder)

IndicationStatusPhase
DBCOND0044076 (Chronic Lung Disease of Prematurity)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00215540SURFAXIN® Treatment for Prevention of Bronchopulmonary Dysplasia (BPD) in Very Low Birth Weight (VLBW) Infants.Prevention